Caliway to Present the Latest Clinical Advancements at 2024 BIO International Convention By Investing.com

new Taipei city, May 11, 2024 /PRNewswire/ — Calliway Biopharmaceuticals (Calliway) is pleased to announce its partnership to share the latest clinical developments in the upcoming 2024 year Vital International Convention on Wednesday, June 5in 11:45 AM PT. The presentation will take place at Theater show company 2 in San Diego Convention Center.

Annual Vital International Conventionsponsored by Biotechnology Innovation Organization (BIO), is the world's leading industry event, bringing together more than 20,000 respected biotechnology and pharmaceutical leaders from nearly 5,000 prestigious companies. The four-day in-person event includes cutting-edge forums, networking and partnership opportunities. Caliway is one of more than 200 companies preparing to attend the event.

Calliway anticipates this opportunity to share recent progress on its lead pipeline candidate, CBL-514, with the international biotechnology and pharmaceutical community. Phase II studies of CBL-514 have demonstrated efficacy in multiple indications. For subcutaneous fat reduction, an average of 312.1 ml was achieved. It has also shown promising results in treating Dercum's disease as well as cellulite. These findings represent an important step forward in providing effective solutions for these medical conditions.

on Calliway Biopharmaceuticals

Calliway Biopharmaceuticals Callaway is a Taiwan– A headquartered clinical-stage biopharmaceutical company, driven by the discovery of advanced small molecule therapeutics with a focus on medical aesthetics and inflammatory diseases.

Listed on the emerging stock market in Taiwan (TPEX6919), Calliway aims to become an innovative pharmaceutical leader in aesthetic medicine. For more information, please visit: http://www.Caliway.com.tw/en

Disclaimer

This article and related information on this site contain forward-looking statements. Forward-looking information requires the Company to make numerous assumptions and is subject to inherent risks, uncertainties and other factors beyond the Company's control that may cause actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. The Company undertakes no obligation to communicate, update or revise the information on this Site in a timely manner if circumstances change.

For further contact: info@caliway.com.tw

Third Party Advertising. It is not an offer or recommendation from Investing.com. See disclosure here or
Remove ads
.